Genscript Biotech Corporation (HKG: 1548)

Genscript Biotech Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 9, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	27,248	42,166	52,563	72,496	22,033	33,204
Market Cap Growth	-52.57%	-19.78%	-27.50%	229.03%	-33.64%	71.32%
Enterprise Value	25,058	38,022	47,670	64,744	14,836	29,496
Last Close Price	12.80	19.86	24.85	34.50	11.28	17.70
PE Ratio	-	-56.12	-29.45	-25.04	-13.49	-43.45
PS Ratio	3.43	6.43	10.77	18.97	7.27	15.59
PB Ratio	2.87	2.64	4.95	6.70	3.48	11.45
P/FCF Ratio	-8.29	-10.01	-20.04	-34.45	-10.41	-30.38
P/OCF Ratio	-113.88	-18.81	-56.04	-67.97	-18.81	-142.31
EV/Sales Ratio	3.18	5.80	9.77	16.94	4.90	13.85
EV/EBITDA Ratio	-6.49	-13.58	-15.72	-24.31	-10.95	-33.70
EV/EBIT Ratio	-5.33	-11.71	-13.96	-21.89	-9.35	-28.83
EV/FCF Ratio	-11.75	-9.02	-18.17	-30.77	-7.01	-26.99
Debt / Equity Ratio	0.54	0.41	0.48	0.30	0.07	0.06
Debt / FCF Ratio	-3.62	-1.56	-1.95	-1.55	-0.20	-0.17
Asset Turnover	0.30	0.28	0.26	0.27	0.33	0.30
Inventory Turnover	9.15	7.59	6.17	5.46	5.60	6.44
Quick Ratio	3.97	4.50	2.99	3.80	2.85	2.28
Current Ratio	4.15	4.76	3.23	3.97	3.03	2.47
Return on Equity (ROE)	-16.62%	-20.85%	-31.12%	-47.05%	-47.38%	-27.15%
Return on Assets (ROA)	-6.40%	-8.76%	-11.45%	-12.88%	-10.94%	-9.09%
Return on Capital (ROIC)	-7.44%	-10.59%	-14.32%	-17.72%	-20.18%	-18.24%
Earnings Yield	-7.82%	-1.77%	-3.37%	-3.86%	-7.21%	-2.27%
FCF Yield	-12.06%	-9.99%	-4.99%	-2.90%	-9.61%	-3.29%
Buyback Yield / Dilution	-0.43%	-0.58%	-3.28%	-6.83%	-2.53%	-0.78%
Total Shareholder Return	-0.43%	-0.58%	-3.28%	-6.83%	-2.53%	-0.78%

Source: S&P Capital IQ. Standard template. Financial Sources.